What SkinIO does

SkinIO, Inc. is a Chicago-based digital health company that has built an AI-powered, smartphone-based platform for skin cancer screening and longitudinal skin health monitoring. The core product is the SkinIO mobile app (iOS and Android), which guides users through a structured 10-minute photo-capture process covering approximately 90% of the body's surface. Captured images are encrypted, removed from the device, and uploaded to HIPAA-compliant cloud storage, where AI-driven computer vision and anomaly detection identify suspicious spots or changes (claimed sensitivity down to 1mm). Board-certified dermatologists then review the AI-assisted output and return medical recommendations within 2–3 days; a "Connection to Care" team fast-tracks patients needing in-person follow-up to in-network dermatologists within 2–3 weeks. Each scan feeds a longitudinal digital skin health record that supports change-over-time comparison.

The platform is delivered through two distinct go-to-market motions. On the consumer side, individuals purchase one-time screenings directly via the app at a $239 price point (with promotional pricing at $189). On the enterprise side, SkinIO sells into large self-funded employers, labor unions, and health systems as a preventive wellness benefit — named customers include MetroHealth System, a Chicago-based airline, Signature Custom Cabinetry, and Aspire Ventures, totaling approximately 90 customers nationwide. Enterprise distribution is being actively expanded through partnerships with Smart Health Innovation Lab, MSK Direct (Memorial Sloan Kettering's cancer care benefits network), and ACP's Employee Health & Wellness Conference in 2025, alongside a dermatology clinician-facing module for in-office augmentation.

SkinIO generates revenue from one-time consumer screening fees and recurring B2B subscription or per-employee contracts with enterprise customers. The company is venture-backed, having raised more than $6.5 million cumulatively from individual investors including Citadel founder Ken Griffin and former Walgreens executive Stewart Wasson, with disclosed funding rounds in 2015, 2019, and 2020. Headcount sits in the 11–50 range, with a three-person engineering team that maintains HIPAA expertise. The company competes in the global teledermatology market, valued at $16.71 billion in 2025 with a projected 16.72% CAGR through 2034, and the AI-powered tele-dermatology triage segment ($2.8 billion in 2025, projected to $9.4 billion by 2034).

Name

SkinIO

Legal name

SkinIO, Inc.

Website

https://skinio.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

SkinIO is a Chicago-based health technology company offering AI-powered smartphone skin cancer screening with board-certified dermatologist review, serving individual consumers via a $239 mobile app and enterprises (employers, health systems, unions) as a workplace wellness benefit.

Ownership category

akta.pro rank

Product category

Teledermatology Software

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Dermatology Telemedicine Platforms (HLALAGAA)

akta.pro secondary industry

General & Medical Dermatology (HLAKACAA)

Keywords

• Skin cancer screening
• Teledermatology platform
• AI skin imaging
• Employee wellness benefits
• Digital skin health record

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Direct-to-Consumer Screening: Individual consumers purchase one-time skin cancer screenings through the SkinIO app for $239. Each screening includes a full-body photo capture, dermatologist review, and results delivered in 2-3 days.
2. Enterprise/B2B Employee Benefits: SkinIO sells its screening platform as an employee health benefit to large employers, unions, and health systems (such as MetroHealth System). B2B contracts likely involve per-employee/per-screening pricing or subscription arrangements.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

SkinIO provides an AI-powered smartphone-based skin cancer screening platform that guides users through a 10-minute full-body photo capture, uploads images to a HIPAA-compliant cloud for review by board-certified dermatologists, and delivers medical recommendations in 2-3 days. The platform operates a direct-to-consumer mobile app at $239 per screening and also offers enterprise solutions for employers, unions, health systems, and clinicians, including a Connection to Care service that fast-tracks patients needing follow-up to in-network dermatologists within 2-3 weeks.

Product overview

SkinIO is a health technology company offering an AI-powered skin cancer screening platform. The core offering consists of the SkinIO mobile app for consumer skin screening and the Connection to Care service for dermatologist referrals. The platform enables 10-minute smartphone-based full-body skin scans with board-certified dermatologist review delivered within 2-3 days. Enterprise offerings include dedicated solutions for employers, health systems, unions, and clinicians. The dermatologist-facing platform provides tools for image review, spot annotation, and longitudinal tracking. Priced at $239 per screening (with promotional pricing at $189 available).

Differentiator

Problem solved

Functional benefit

Products and services

• SkinIO Mobile App Consumer-facing mobile application available on iOS and Android that enables individuals to complete a full-body skin cancer screening from home in 10 minutes using their smartphone. The app guides users through the photo-taking process and uploads images for board-certified dermatologist review.
• Connection to Care Care coordination service that fast-tracks users whose SkinIO scan flags concerning findings to in-network dermatologists for in-person follow-up, with appointments typically scheduled within 2-3 weeks.
• SkinIO for Employers Enterprise offering that provides large employers with SkinIO's skin cancer screening technology as an employee health benefit, aimed at controlling healthcare costs and improving workforce health outcomes through early detection.
• SkinIO for Health Systems Healthcare system integration that enables hospitals and health systems to offer SkinIO's skin cancer screening technology to their patient populations as part of integrated care pathways.
• SkinIO for Clinicians Dermatologist-facing clinical platform that allows clinicians to review patient-submitted skin images, annotate spots with notes and dermoscopic images, mark them as new, changed, or suspicious, and track changes over time across visits.
• SkinIO for Unions Union benefit offering that provides union members with access to SkinIO's skin cancer screening services as part of their member health benefits package.
• SkinIO Web Application Web-based platform that allows users to access their SkinIO accounts, review screening results, and manage their longitudinal digital skin health records through a browser.

Quantifiable outcome

• Detects changes in skin down to 1mm
• +4 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• MSK DirectcoreGTM or Marketing Partner · 6 May 2025SkinIO was featured in the Innovator Spotlight at MSK Direct Benefits Leaders' Summit in New York City, showcasing AI-powered skin cancer screening platform to benefits leaders from major employers.
• City of DreamsminorOthers · 14 April 2025San Francisco-based nonprofit dedicated to empowering youth in underserved neighborhoods. SkinIO donated to support their mission, reflecting broader commitment to community wellbeing.
• ACP (Advanced Career Strategies)coreGTM or Marketing Partner · 2 March 2025SkinIO participated in the ACP Employee Health & Wellness Conference, an exclusive event connecting top benefits executives with innovative healthcare solution providers.
• Smart Health Innovation LabcoreStrategic or Co-development PartnerSmart Health Innovation Lab partnered with SkinIO to bring virtual skin cancer screenings to Lancaster County. SkinIO provides at-home and on-site skin cancer screenings to employees of Signature Custom Cabinetry and Aspire Ventures, an investor/founder of the Innovation Lab.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• SkinVision: SkinVision is an Amsterdam-based AI-powered skin cancer detection app with regulatory clearances (CE-marked, TGA-approved). It is the closest direct competitor to SkinIO, offering smartphone-based skin lesion risk assessment with teledermatology follow-up pathways.
• Miiskin: Miiskin offers a smartphone-based mole and skin tracking app with AI-assisted photo comparison and partner dermatologist review. It serves a similar consumer self-monitoring niche and shares SkinIO's longitudinal skin-photo record feature.
• DermaSensor: DermaSensor is an FDA-cleared (2024) handheld device that uses AI and spectroscopy to evaluate skin lesions for primary care clinicians. It addresses the same skin cancer early-detection problem as SkinIO but through a clinical device rather than a smartphone app, making it a direct competitor for clinician and health system channels.
• FotoFinder: FotoFinder ( FotoFinder Systems GmbH) is a German specialist in total body photography and AI-assisted mole mapping for dermatology clinics. It competes with SkinIO for dermatologist and health system accounts that need longitudinal skin imaging, though its deployment model is hardware-based clinical installs rather than consumer smartphones.
• MetaOptima: MetaOptima built the DermEngine platform for dermatology imaging and AI skin lesion analysis, used by clinics and teledermatology services. It overlaps with SkinIO's clinician and health system offerings and is a credible direct competitor in AI dermatology decision support.
• First Derm: First Derm operates an asynchronous teledermatology platform connecting users to board-certified dermatologists for image-based consultations. It targets a similar consumer and enterprise use case as SkinIO but uses a per-consultation ticket model rather than an annual screening subscription.

Broad incumbents

• Canfield Scientific: Canfield Scientific is a long-established US leader in dermatology imaging systems, including VECTRA total body photography and DermaGraphix software. It sells primarily to dermatology practices and competes with SkinIO at the clinician-facing end of the market with significantly more capital and installed base.
• Teladoc Health: Teladoc is the largest US telehealth platform with broad specialty coverage and enterprise contracts that easily absorb dermatology. As a broad incumbent, it could bundle or build a competing skin screening offering, putting enterprise channel pressure on SkinIO's go-to-market.
• Amwell: Amwell is an enterprise telehealth platform serving health systems and health plans with multi-specialty virtual care. It competes with SkinIO at the health system channel level and has the capital to acquire or build a teledermatology offering at scale.

Emerging players

• MoleScope: MoleScope by MetaOptima offers a smartphone-attachable dermatoscope with the DermEngine app for mole tracking and teledermatology. It overlaps meaningfully with SkinIO on consumer smartphone-based skin monitoring while adding a hardware component that targets more clinical mole-mapping use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/mySkinIO
• Facebookfacebook.com/mySkinIO
• LinkedInlinkedin.com/company/skinio
• Instagraminstagram.com/mySkinIO

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SkinIO